EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

Clusterin ameliorates LPS-induced ARDS by inhibiting the Wnt/β-catenin pathway

Rui Tang, Wen Tang, Hao Hu, Junnan Peng iD, Daoxin Wang

Clinical Science · 12.08.2026 · 140 (8) · 1635-1652

DOI: 10.1042/cs20251056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, online erschienen am 10.07.2026. Verfasst von Rui Tang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Chongqing Medical University, No.76 Linjiang Road, Yuzhong Distri…. Hauptthemen laut MEDLINE: Clusterin, Wnt Signaling Pathway, Respiratory Distress Syndrome. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute respiratory distress syndrome (ARDS) is a critical illness characterized by endothelial barrier damage, and the present study investigates the specific role of clusterin (CLU). The study found that CLU concentrations were significantly lower in ARDS patients, particularly non-survivors, compared with non-ARDS patients and survivors; similarly, serum CLU levels were decreased in mice with lipopolysaccharide-induced ARDS. Both in vivo and in vitro experiments demonstrated that treatment with recombinant CLU protein significantly alleviated organ injury and suppressed the inflammatory response. Mechanistically, CLU improves mitochondrial oxidative phosphorylation by inhibiting the Wnt/β-catenin signaling pathway, thereby inhibiting the expression of inflammatory factors, repairing adherens junctions, and reducing vascular leakage, ultimately preserved intercellular junction protein expression. In summary, CLU ameliorates endothelial injury in ARDS models by inhibiting the Wnt/β-catenin pathway, playing a crucial protective role in host defense against ARDS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClusterinWnt Signaling PathwayRespiratory Distress SyndromeAnimalsLipopolysaccharidesHumansMaleMice, Inbred C57BLbeta CateninDisease Models, AnimalMiceFemale

Stichwörter der Autor:innen

APOJARDSClusterinwnt/β-catenin

Substanzen

ClusterinLipopolysaccharidesbeta CateninCLU protein, human

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Chongqing Medical University, No.76 Linjiang Road, Yuzhong District, Chongqing 400010, China.

ORCID-Profile: Junnan Peng

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)

Zitieren

APA

Tang, R., Tang, W., Hu, H., Peng, J., & Wang, D. (2026). Clusterin ameliorates LPS-induced ARDS by inhibiting the Wnt/β-catenin pathway. Clinical Science, 140(8), 1635-1652. https://doi.org/10.1042/cs20251056

Vancouver

Tang R, Tang W, Hu H, Peng J, Wang D. Clusterin ameliorates LPS-induced ARDS by inhibiting the Wnt/β-catenin pathway. Clinical Science. 2026;140(8):1635-1652. doi:10.1042/cs20251056

BibTeX
@article{Tang2026,
  author = {Tang, Rui and Tang, Wen and Hu, Hao and Peng, Junnan and Wang, Daoxin},
  title = {Clusterin ameliorates LPS-induced ARDS by inhibiting the Wnt/β-catenin pathway},
  journal = {Clinical Science},
  year = {2026},
  volume = {140},
  number = {8},
  pages = {1635--1652},
  doi = {10.1042/cs20251056}
}
Kostenlos starten →